RALGA (Diacnéal®), a retinaldehyde and glycolic acid association and postinflammatory hyperpigmentation in acne - A review

Dermatology

Volumn 210, Issue SUPPL. 1, 2005, Pages 39-45

  Katsambas, A D ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Acne; Glycolic acid; Hyperpigmentation; Retinaldehyde

Indexed keywords

ANTI ACNE AGENT; DERMATOLOGICAL AGENT; DIACNEAL; GLYCOLIC ACID; HYDROQUINONE PLUS GLYCOLIC ACID; KOJIC ACID; KOJIC ACID PLUS GLYCOLIC ACID; RETINAL; RETINALDEHYDE PLUS GLYCOLIC ACID; RETINOIC ACID; UNCLASSIFIED DRUG; GLYCOLIC ACID DERIVATIVE; KERATOLYTIC AGENT;

ACNE; ACNE VULGARIS; ANTIBACTERIAL ACTIVITY; CHLOASMA; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG TOLERABILITY; EPITHELIZATION; HUMAN; HYPERPIGMENTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SKIN INFLAMMATION; ULTRAVIOLET RADIATION; ADOLESCENT; DRUG COMBINATION; REVIEW;

ACNE VULGARIS; ADOLESCENT; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; DRUG SYNERGISM; GLYCOLATES; HUMANS; HYPERPIGMENTATION; KERATOLYTIC AGENTS; RETINALDEHYDE;

EID: 16344368472     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081501     Document Type: Conference Paper

References (51)

1. Jacyk WK: Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol 2001;15:37-42.
2. Daniel F, Dréno B, Poli F, Auffret N, Beylot C, Bodokh I, et al: Epidémiologie descriptive de l'acné dans la population scolarisée en France métropolitaine pendant l'automne 1996. Ann Dermatol Vénéréol 2000;127:273-278.
3. Baur DA, Butler RCD: Current concepts in pathogenesis and treatment of acne. J Oral Maxillofac Surg 1998;56:651-655.
4. Kenney JA Jr: Pigmentary disorders in black skin. Clin Dermatol 1989;7:1-10.
5. Grimes PE, Stockton T: Pigmentary disorders in blacks. Dermatol Clin 1988;6:271-281.
6. McDonald CJ: Dermatological problems in black skin. Prog Dermatol 1973;7:15-20.
7. Al-Waiz MM, Al-Sharqi AI: Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. Dermatol Surg 2002;28:383-387.
8. Kenney JA: Dermatoses common in blacks. Postgrad Med 1977;81:122-127.
9. Hearing VJ, Tsukamoto K: Enzymatic control of pigmentation in mammals. FASEB J 1991;5:2902-2907.
10. Romero C, Aberdam E, Larnier C, Ortonne J: Retinoic acid as modulator of UVB-induced melanocyte differentiation - Involvement of the melanogenic enzymes expression. J Cell Sci 1994;107:1095-1103.
11. Burchill SA, Bennett DC, Holmes A, Thody AJ: Tyrosinase expression and melanogenesis in melanotic and amelanotic B16 mouse melanoma cells. Pathobiology 1991;59:335-339.
12. Edward M, Gold JA, Mackie RM: Different susceptibilities of melanoma cells to retinoic acid induced changes in melanotic expression. Biochem Biophys Res Commun 1988;155:773-778.
13. Bulengo SM, Griffiths C, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN, Voorhees JJ: Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med 1993;328:1438-1443.
14. Lucky A, Cullen S, Jarratt M: Comparative efficacy and safety of two 0.025% tretinoin gels: Results from a multicenter, double-blind, parallel study. J Am Acad Dermatol 1998;38:17-23.
15. Shalita A, Weiss J, Chalker D, Ellis C, Greenspan A, Katz H, Kantor I, Millikan L, Swinehart T, Swinyer L, Whitmore C, Baker M, Czernilewski J: Comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial. J Am Acad Dermatol 1996;34:482-485.
16. Gollnick H, Krautheim A: Topical treatment in acne: Current status and future aspects. Dermatology 2003;206:29-36.
17. Garcia A, Fulton JE: The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996;22:443-447.
18. Pathak MA, Fitzpatrick TB, Parish JA: Treatment of melasma with hydroquinone. J Invest Dermatol 1993;76:324-329.
19. Wolf JE Jr: Maintenance therapy for acne vulgaris: The fine balance between efficacy, cutaneous tolerability, and adherence. Skinmed 2004;3:23-26.
20. Leyden J: Topical treatment of acne vulgaris: Retinoids and cutaneous irritation. J Am Acad Dermatol 1998;38:1-4.
21. Gollnick H, Cunliffe W, Berson D, Dréno B, Finlay A, Leyden J, Shalita A, Thiboutot D: Management of acne: A report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003;49:S1-S37.
22. Hadler RM: The role of retinoids in the management of cutaneous conditions in blacks. J Am Acad Dermatol 1998;39:S98-S103.
23. Tung RC, Bergfeld WF, Vidimos AT, Remzi BK: α-Hydroxy acid-based cosmetic procedures - Guidelines for patients. Am J Clin Dermatol 2000;1:81-88.
24. Saurat JH, Didierjean L, Masgrau E, et al: Topical retinaldehyde on human skin: Biological effects and tolerance. J Invest Dermatol 1994;103:770-774.
25. Edwards H: Topical retinol and retinaldehyde in cosmetics as alternatives to retinoic acid: Evidence of efficacy. Retinoids 2001;17:98-102.
26. Fort-Lacoste L, Verscheure Y, Tisne-Versailles J, Navarro R: Comedolytic effect of topical retinaldehyde in the rhino mouse model. Dermatology 1999;199(suppl 1):33-35.
27. Lachgar S, Chaveron M, Gall Y, et al: Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes. Dermatology 1999;199:25-27.
28. Pechère M, Pechère JC, Siegenthaler G, et al: Antibacterial activity of retinaldehyde against Propionibacterium acnes. Dermatology 1999;199:29-31.
29. Pechère M, Germanier L, Siegenthaler G, Pechère JC, Saurat J-H: The antibacterial activity of topical retinoids: The case of retinaldehyde. Dermatology 2002;205:153-158.
30. Creidi P, Veinne MP, Ochonisky S, et al: Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol 1998;39:960-965.
31. Fort-Lacoste L, Navarro R, Gooris E: Propriétés dépigmentantes du rétinaldéhyde. Congrès Annuel de Recherche Dermatologique, Toulouse, 1997, Scientific Monograph, p 54.
32. Morel P, Vienne MP, Beylot C, Bonérandi JJ, Dréno B, Lehucher-Ceyrac D, Slimani S, Dupuy P: Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. Clin Exp Dermatol 1999;24:354-357.
33. Van Scott EJ, Lui RJ: Alpha hydroxyl acids: Procedures for use in clinical practice. Cutis 1989;43:222-228.
34. Bergfeld W, Tung R, Vidimos A, et al: Improving the appearance of photoaged skin with glycolic acid. J Am Acad Dermatol 1997;36:1011-1013.
35. Clark CP: Alpha hydroxy acids in skin care. Clin Plast Surg 1996;23:49-56.
36. Dinardo JC, Grove GL, Moy LS: Clinical and histological effects of glycolic acid at different concentrations and pH levels. Dermatol Surg 1996;22:421-424.
37. Newman N, Newman A, Moy LS, et al: Clinical improvement of photoaged skin with 50% glycolic acid. Dermatol Surg 1996;22:455-460.
38. Murad H, Shamban AT, Premo PS: The use of glycolic acid as a peeling agent. Dermatol Clin 1995;13:285-307.
39. Arndt KA, Fitzpatrick TP: Topical use of hydroquinone as a depigmentation agent. J Am Med Assoc 1963;194:117-119.
40. Kligman A, Willis I: A new formula for depigmenting human skin. Arch Dermatol 1975;111:40-48.
41. Kasraee B, Handjani F, Aslani FS: Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all-trans-retinoic acid (trenitoin): The impairment of glutathione-dependent cytoprotection? Dermatology 2003;206:289-291.
42. Moy LS, Murad H, Moy RL: Glycolic acid peels for treatment of wrinkles and photoaging. J Dermatol Surg Oncol 1993;19:243-246.
43. Lim JTE, Tham SN: Glycolic acid in the treatment of melasma among Asian women. Dermatol Surg 1997;23:177-179.
44. Didierjean L, Carraux P, Grand D, et al: Topical retinaldehyde increases skin content of retinoic acid and exerts biologic activity in mouse skin. J Invest Dermatol 1996;107:714-719.
45. Orlow SJ, Chakraborty AK, Pawelek JM: Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol 1990;94:461-464.
46. Stiller NJ, Bartolone J, Stern R, et al: Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photoaged skin: A double-blind vehicle-controlled clinical trial. Arch Dermatol 1996;132:631-635.
47. Kim SJ, Park JH, Kim DH, et al: Increased in vivo collagen synthesis and in vitro cell collagen synthesis and in vitro cell proliferative effect of glycolic acid. Dermatol Surg 1998;24:1054-1058.
48. Kasraee B, Tran C, Sorg O, Saurat J-H: The depigmenting effect of RALGA in C57BL/6 mice. Dermatology 2005;210(suppl 1):30-34.
49. Boisnic S, Branchet-Gumila M-C, Nocera T, Verrière F: RALGA decreases melanin content in a human skin model. Dermatology 2005;210(suppl 1):35-38.
50. Bordat P, Chesnoy S: Mixing glycolic acid with retinaldehyde: RALGA, a technical achievement. Dermatology 2005;210(suppl 1):2-5.
51. Poli F, Ribet V, Lauze C, Adhoute H, Morinet P: Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (Diacnéal™) for mild to moderate acne vulgaris. Dermatology 2005;210(suppl 1):14-21.